Goblet Cell Dysfunction and Gut Mucus Disruption
Multiple sclerosis patients exhibit goblet cell dysfunction marked by a significant reduction of Alcian Blue-positive and UEA-1-positive goblet cells in intestinal crypts, Nature reported. Researchers investigating gut modifications in multiple sclerosis analyzed duodenal biopsies and fecal samples from patients and healthy controls using histology, flow cytometry, qPCR, and fecal metagenomic whole-genome sequencing.
The mucus layer acts as an important component of the gut barrier that regulates host-microbiota interactions. Mucus-secreting goblet cells and mucus-associated immune pathways promote tolerance and regulatory T-cell differentiation. These mechanisms maintain immune homeostasis in the gut and in extra-intestinal tissues including the central nervous system.
Microbiota Shifts and Immune Regulation
Fecal metagenomic analysis revealed a higher relative abundance of species with reported mucin-degrading capacity in multiple sclerosis patients. These species include A. muciniphila, A. glycaniphila, B. cellulosilyticus, and P. coprophilus. At the same time, the data showed a reduced relative abundance of species reported to support goblet cell differentiation and maturation, such as B. breve and C. butyricum.
Immunophenotyping of the samples demonstrated a reduction of intestinal FoxP3-positive regulatory T cells. In EAE-immunized mice, enzymatic disruption of the mucus barrier worsened CNS autoimmunity. These findings support a functional link between mucus barrier integrity and neuroinflammation.
Therapeutic Potential and Future Research
These data indicate that mucus barrier integrity is associated with the regulation of CNS autoimmunity. The results suggest that restoring mucus integrity may represent a therapeutic strategy in multiple sclerosis. Protecting or restoring the intestinal mucus barrier integrity could help support immune balance and prevent disease relapses.
Common Questions About Gut Mucus and Multiple Sclerosis
What specific changes occur in the gut mucus of multiple sclerosis patients?
Patients show goblet cell dysfunction with a significant reduction of Alcian Blue-positive and UEA-1-positive goblet cells in intestinal crypts, alongside a decrease in intestinal FoxP3-positive regulatory T cells.
How do gut bacteria change in individuals with multiple sclerosis?
Fecal metagenomic analysis shows a higher relative abundance of mucin-degrading species like A. muciniphila and P. coprophilus, coupled with reduced levels of species that support goblet cell maturation like B. breve.
What effect did disrupting the mucus barrier have on mice in the study?
In EAE-immunized mice, enzymatic disruption of the mucus barrier worsened central nervous system autoimmunity, demonstrating a functional link between barrier integrity and neuroinflammation.
Related reading